Anupco


ANCOSPECTIN 150

Solution for Injection

COMPOSITION

Lincomycinium (lincomycini hydrochloridum) 50 mg – Spectinomycinum (spectinomycini sulfas) 100 mg – Excipients up to 1ml.

PHARMACEUTICAL FORM

Injectable solution.

INDICATIONS

Infections caused by gram positive and gram negative bacteria, spirochetes, mycoplasms, anaerobes and mixed infections. ANCOSPECTIN 150 can be used in the treatment of the following diseases:

Pigs: bacterial and mycoplasma pneumonia, pleuropneumonia (Haemophylus), atrophic rhinitis, dysentery, bacterial enteritis, infectious arthritis, erysipelas and bacterial infections secondary to viral ones.

Calves: respiratory disease, often associated as pneumo-enteritis, mycoplasma arthritis.

Sheep and goats: pneumonia, virulent foot-rot, contagious agalactia.

Dogs: respiratory infections.

Poultry: early chick mortality, fowl cholera, chronic respiratory disease.

CONTRA-INDICATIONS

As all drugs,áANCOSPECTIN 150áis not to be used in animals with known hypersensitivity towards this product. Use in other species than target animals may cause gastro-intestinal disturbances.

DOSAGE AND ADMINISTRATION

Pigs: 1 ml ANCOSPECTIONá150 per 10 kg bodyweight (15 mg/kg) intramuscular.áDose may be repeated every 24 hours for 3 to 7 days.

Calves, sheep, goats: 1 ml ANCOSPECTIN 150 per 10 kg bodyweight (15 mg/kg) intramuscular. Twice the first day followed by 1 injection per 24 hours for 2 to 4 days.

Dogs: 0.2 ml ANCOSPECTIN 150 per kg bodyweight.

Poultry: 1 day old chicks: IM injection of 100 mg/kg (0.03 ml/ animal with BW of 40 g). 4 week old animals: 60 mg/kg or 0.4 ml per kg BW

SIDE EFFECTS

A slight local irritation at the injection site may occur, disappearing within a few days.

INTERACTIONS WITH OTHER DRUGS

Do not mix with other drugs in the same syringe.

CONSERVATION

Store below 25oC.

PACK SIZE

100ml and 250 ml vials.

 

Prescription only medicine.

Please be aware that product specifications and availability can differ between countries. For detailed information in this regard, please contact us.

 

 

 

You are viewing the English version of this website enesfr